The objectives of this study were to assess CYP2C19 genotypes in a British–South Asian ancestry cohort and to correlate inferred metabolizer phenotypes with recurrent myocardial infarction (MI) events in participants prescribed clopidogrel. The gene discussed is CYP2C19; the disease is myocardial infarction.